ECCS-50

May 26, 2016May 26, 2016

Promising Scleroderma Clinical Trial May Improve Hand Dysfunction

News, Scleroderma

Cytori Therapeutics provided a recent update on results from clinical trials assessing the use of Cytori Cell Therapy (ECCS-50) in the treatment of scleroderma-related hand dysfunction. The presentation was made during the 104th Annual Meeting of the ... Read more

March 30, 2016April 4, 2016

Cytori Updates Phase 3 Scleroderma Trial After Enrolling, Treating 40th Patient

News, Scleroderma

Cytori Therapeutics recently announced that its FDA-approved Phase 3 STAR clinical trial on ECCS-50 has enrolled and treated its 40th patient, reaching 50 percent of its target enrollment. Additionally, an independent ... Read more

September 15, 2015November 6, 2015

Cytori Therapeutics’ Scleroderma Therapy Shows Promising Results After 12 Months of Treatment

News, Scleroderma

Cytori Therapeutics a late stage cell therapy company developing autologous cell therapies from adipose tissue to treat a variety of medical conditions, recently announced the results from a 12-month follow-up of patients ... Read more